The human cardiovascular system functions normally or abnormally based on pressure and flow within blood vessels and cardiac chambers. The future of cardiovascular medicine will see a reliance on implantable pressure sensors that can detect, and wirelessly report, pressures within chambers to external signal receivers, and then to treating clinicians.

This allows for real-time assessment of a person’s cardiovascular function and can expedite treatment before the development of serious consequences. In addition, it will enable remote monitoring—especially for rural and remote populations—and will facilitate specialist interventions from anywhere, including field operations. We have the tools for preclinical and clinical testing of these implantable sensors.

Competitive advantage

  • Excellent track record in preclinical testing and early phase clinical trials
  • Expertise in cardiovascular haemodynamic evaluation

Successful applications of research

  • Patients with heart failure can be treated before they require hospitalisation
  • Remote telehealth treatment of patients with heart disease will become feasible


  • Measurement of pressures from within the cardiovascular system has the potential to revolutionise cardiac care
  • Early detection will prevent hospitalisations from heart failure
  • Telehealth treatment will improve health for rural, remote and Indigenous patients

Capabilities and Facilities

  • Small and large animal preclinical testing
  • Clinical researchers with experience in early phase clinical studies
  • Large patient group requiring this technology
  • Telemedicine service in which to test the results

Further reading on: Advanced Sensors and Intelligence

The University of Newcastle acknowledges the traditional custodians of the lands within our footprint areas: Awabakal, Darkinjung, Biripai, Worimi, Wonnarua, and Eora Nations. We also pay respect to the wisdom of our Elders past and present.